Literature DB >> 12964013

A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion.

Anne Murati1, José Adélaïde, Cornel Popovici, Marie-Joëlle Mozziconacci, Christine Arnoulet, Marina Lafage-Pochitaloff, Danielle Sainty, Daniel Birnbaum, Max Chaffanet.   

Abstract

We report here the sixth case of acute monoblastic leukemia associated with the inv(8)(p11q13) pericentric inversion. As seen in the previous cases, the inv(8)(p11q13) molecular characterization showed that the alteration results in a MOZ-NCOA2 gene fusion. The presence of erythrophagocytosis is a distinctive morphologic feature that is observed in all patients with MOZ alteration. However, the relative young age of the 6 patients (median: 23.5 years) and same sex (female) are the common characteristics that are only observed in the inv(8)-positive leukemia subgroup. In addition, we tested whether the presence of FLT3 internal duplications (ITD) are frequently found in malignant hemopathies with 8p11-12 rearrangements. We did not find any FLT3 ITD in any of the studied cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964013

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  3 in total

Review 1.  Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.

Authors:  Aliaa Arina Rosli; Adam Azlan; Yaashini Rajasegaran; Yee Yik Mot; Olaf Heidenreich; Narazah Mohd Yusoff; Emmanuel Jairaj Moses
Journal:  Clin Exp Med       Date:  2022-10-13       Impact factor: 5.057

2.  MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.

Authors:  Karin B Kindle; Philip J F Troke; Hilary M Collins; Sachiko Matsuda; Daniela Bossi; Cristian Bellodi; Eric Kalkhoven; Paolo Salomoni; Pier Giuseppe Pelicci; Saverio Minucci; David M Heery
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

3.  Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.

Authors:  Véronique Gelsi-Boyer; Virginie Trouplin; José Adélaïde; Nicola Aceto; Virginie Remy; Stephane Pinson; Claude Houdayer; Christine Arnoulet; Danielle Sainty; Mohamed Bentires-Alj; Sylviane Olschwang; Norbert Vey; Marie-Joëlle Mozziconacci; Daniel Birnbaum; Max Chaffanet
Journal:  BMC Cancer       Date:  2008-10-16       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.